By admin 
The Federal Trade Commission is examining Epic Systems Corp., the nation’s largest vendor of electronic health records, for potential violations of antitrust law as part of a broad inquiry into the company’s business practices, according to four people who were recently contacted by investigators. This preliminary probe signals a significant escalation in federal scrutiny of the private, Verona, Wisconsin-based company that serves as the digital backbone for the majority of the United States’ leading medical centers. While the investigation is in its nascent stages and may not ultimately result in formal charges, the breadth of the FTC’s questions suggests a deep dive into how Epic maintains its stranglehold on the healthcare IT market.
The individuals contacted by federal investigators—a group comprising healthcare executives, consultants, and technology competitors—indicated that the government’s interest is bifurcated into two primary areas of concern: restrictive labor practices and the strategic suppression of data interoperability. These allegations have long simmered within the industry, occasionally boiling over into lawsuits and public disputes, but the FTC’s involvement marks the first time the company has faced such a comprehensive federal antitrust review in recent history.
Epic Systems, founded in 1979 by Judy Faulkner, has grown from a small basement operation into a multi-billion-dollar juggernaut. Unlike many of its peers in the tech sector, Epic remains a private company, a status that Faulkner has vowed to maintain to avoid the short-term pressures of Wall Street. This private status has allowed the company to cultivate a unique corporate culture and a highly integrated, albeit closed, ecosystem. According to data from KLAS Research, Epic currently controls approximately 36% of the U.S. acute care hospital market and an even more staggering percentage of large, academic medical centers with over 500 beds. In many major metropolitan areas, Epic’s market share is essentially a monopoly, with virtually every major hospital system utilizing its software to manage patient records, billing, and clinical workflows.
The first line of the FTC’s inquiry focuses on Epic’s controversial employment agreements. For years, the company has utilized aggressive non-compete clauses and "do-not-hire" lists that effectively bar former employees from working for a wide swath of healthcare businesses. These restrictions often extend to Epic’s own customers—the hospitals—and third-party vendors that interface with Epic software. Critics argue that these policies create a "talent lock-in," preventing skilled developers and consultants from taking their expertise to rival firms or startups that might offer competing solutions.
This aspect of the investigation aligns with the broader agenda of FTC Chair Lina Khan, who has made the elimination of non-compete agreements a cornerstone of her tenure. In April 2024, the FTC issued a final rule banning most non-compete agreements nationwide, arguing they suppress wages and stifle innovation. Although that rule has faced legal challenges in federal courts, the FTC’s specific interest in Epic suggests the agency is looking at how these labor restrictions might be used as a tool to maintain a monopoly by starving competitors of the specialized labor force required to build and maintain complex health IT systems.
The second, and perhaps more consequential, prong of the investigation centers on "information blocking" and market leverage. Investigators are reportedly asking whether Epic uses its dominant position to prevent rival technology companies from accessing the patient data necessary to function. In the modern healthcare landscape, data is the most valuable commodity. While Epic’s "Care Everywhere" platform allows for data sharing between different hospitals that both use Epic, third-party developers often complain of significant hurdles when trying to integrate their software with Epic’s proprietary systems.
These hurdles often manifest as exorbitant "integration fees," restrictive API (Application Programming Interface) terms, or technical barriers that make it difficult for a patient’s data to move seamlessly to a non-Epic application. Such practices are at the heart of the 21st Century Cures Act, which was passed by Congress with overwhelming bipartisan support to end the practice of information blocking. The Office of the National Coordinator for Health Information Technology (ONC) has established rules to ensure that patients and providers have easy access to electronic health information, yet many in the industry believe Epic has found ways to comply with the letter of the law while violating its spirit.
The timing of this probe is particularly noteworthy given the recent legal firestorm involving Particle Health, a health data startup. In September 2024, Particle Health filed a federal antitrust lawsuit against Epic, alleging that the EHR giant used its dominance to "snuff out" competition. The lawsuit claims that Epic cut off Particle’s access to its data exchange network, an act Particle describes as a "death blow" to its business model. While Epic has dismissed these claims as meritless, the FTC’s decision to begin an inquiry suggests that federal regulators see the Particle Health dispute not as an isolated incident, but as a potential symptom of a larger pattern of anti-competitive behavior.
Industry experts point out that the stakes of this investigation extend far beyond corporate profits. As healthcare moves toward an era of artificial intelligence and personalized medicine, the control of data becomes a public health issue. Epic’s "Cosmos" database, which contains de-identified records for over 250 million patients, is one of the largest clinical datasets in the world. If Epic is able to restrict who can use this data or how it can be integrated with new AI tools, it could effectively dictate the pace of medical innovation in the United States.
"Epic has built a ‘walled garden’ that is incredibly effective for those inside it, but it creates massive friction for the rest of the ecosystem," said one healthcare IT consultant who spoke on the condition of anonymity due to fear of retribution from the company. "If you are a startup with a brilliant new tool for diagnosing cancer, your success depends entirely on whether Epic decides to let you play in their sandbox. That is an enormous amount of power for one private company to hold over the entire American healthcare system."
The FTC’s investigation also touches upon the concept of "vendor lock-in." Once a hospital system spends hundreds of millions—or in some cases, billions—of dollars to implement Epic, the cost and complexity of switching to a competitor are so high that it becomes practically impossible. This gives Epic immense leverage over its customers. The FTC is likely examining whether Epic uses this leverage to force hospitals into using its own ancillary services—such as its patient portal, MyChart, or its internal analytics tools—at the expense of superior or more affordable third-party options.
In response to past criticisms, Epic has frequently pointed to its success in improving patient safety and streamlining hospital operations. The company argues that its integrated approach reduces medical errors by ensuring that a patient’s entire history is available in one place. They contend that their stringent requirements for third-party developers are not meant to block competition, but to ensure the security and privacy of sensitive patient information.
However, the regulatory environment is shifting. Under the Biden administration, the FTC and the Department of Justice have signaled a renewed willingness to challenge tech monopolies that use their platforms to disadvantage rivals. The investigation into Epic follows similar high-profile actions against companies like Amazon, Google, and Apple. In the healthcare space, the government is increasingly concerned that the "platformization" of medicine is leading to higher costs and less choice for patients.
If the FTC moves forward with an enforcement action, it could seek several remedies. These might include forcing Epic to simplify its data-sharing processes, eliminating its restrictive employment covenants, or even imposing structural changes to how the company licenses its software. A consent decree could also be used to mandate that Epic provide "parity" in data access for third-party apps, ensuring they have the same level of connectivity as Epic’s own internal modules.
For now, the healthcare industry is watching closely. Epic’s influence is so pervasive that any change in its business practices would send shockwaves through every hospital and clinic in the country. As the FTC continues its interviews and data collection, the central question remains: Is Epic’s dominance the result of a superior product and natural market forces, or is it the product of a carefully constructed web of anti-competitive barriers that have left the American healthcare system beholden to a single gatekeeper? The answer to that question will likely define the next decade of digital health in America.
